For further validation of microarray results, qPCR was performed to evaluate the expression patterns of TNXA, CTA-134P22.2, CTC-276P9.1 and KRT19P3 in a total of 51 patients with bladder cancer. This evidence concerns the gene TNXA and urinary bladder carcinoma.